Lennox International: 2026 Q2 Performance and Strategic Shifts
Lennox International Inc., 2026 ikinci çeyreğinde %12'lik düşüşle karşılaşan konut birim hacmini, düşük marjlı yeni inşaat işinden çekilme kararıyla a
Lennox International Inc. reported a 12% decline in residential unit volume for Q2 2026, attributing it to a strategic exit from low-margin new construction. The Building Climate Solutions segment, however, delivered 24% revenue growth, driven by emergency replacement share gains. Residential demand recovery is now expected in 2027 rather than the second half of 2026. The company is expanding its parts and accessories business through direct-to-dealer models and acquisitions like Comfort-Aire. Full-year adjusted EPS guidance was lowered to $23-$24, though commercial demand and acquisition contributions offset lower residential volumes. Production levels have been reduced to manage inventory, creating a $10 million headwind. Capital expenditure guidance was cut from $250 million to $225 million, though core priorities remain intact. Lennox highlighted the 'extremely competitive' residential new construction environment, prioritizing margins over volume. How Will This Impact Markets?
Related News & Analysis
View All →
Moderna's Cancer Vaccine Euphoria Hits Profit-Taking Wall: $18 Billion Wipeout

Singh Joins Mayfield: A New Era for Chip Investments

Ramp Unveils Model Router, Steering the AI Landscape into a New Era

WNBA’s Landmark Pay Raise: 364% Surge in Player Wages Sparks Labor Milestone

Gen Z Rewrites the American Dream in the Great Postponement

Inertia Enterprises Cuts Fusion Fuel Loading to Hours, Shaking the Energy Market
Latest Market News
All News →![[YYAPI] YEŞİL YAPI ENDÜSTRİSİ A.Ş.
Katılım Finansı İlkeleri Bilgi Formu - Katılım Finansı İlkeleri Bilgi Formu](/_next/image?url=%2Fuploads%2Fkap-default.png&w=3840&q=75)
[YYAPI] YEŞİL YAPI ENDÜSTRİSİ A.Ş. Katılım Finansı İlkeleri Bilgi Formu - Katılım Finansı İlkeleri Bilgi Formu

Moderna's Cancer Vaccine Euphoria Hits Profit-Taking Wall: $18 Billion Wipeout
Moderna’s Personalized mRNA Gamble: Oncology Revolution or Market Bubble?
![[GSRAY] GALATASARAY SPORTİF SINAİ VE TİCARİ YATIRIMLAR A.Ş.
Transfer Görüşmelerinin Sonuçlanması veya Sona Ermesi - Profesyonel Futbolcu Aleksei Batrakov Transferi Hakkında](/_next/image?url=%2Fuploads%2Fkap-default.png&w=3840&q=75)
[GSRAY] GALATASARAY SPORTİF SINAİ VE TİCARİ YATIRIMLAR A.Ş. Transfer Görüşmelerinin Sonuçlanması veya Sona Ermesi - Profesyonel Futbolcu Aleksei Batrakov Transferi Hakkında

Norway’s July Oil Production Slump Sends Shockwaves Through European Energy Markets
